Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy

Department of Obstetrics and Gynecology, University of the Philippines College of Medicine-Philippine General Hospital, Taft Avenue, Manila, Philippines, 1000.
Cochrane database of systematic reviews (Online) (Impact Factor: 5.94). 01/2010; DOI: 10.1002/14651858.CD007855.pub2
Source: PubMed

ABSTRACT Asymptomatic bacteriuria occurs in 5% to 10% of pregnancies and, if left untreated, can lead to serious complications.
To assess which antibiotic is most effective and least harmful as initial treatment for asymptomatic bacteriuria in pregnancy.
We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (March 2010) and reference lists of retrieved studies.
Randomized controlled trials comparing two antibiotic regimens for treating asymptomatic bacteriuria.
Review authors independently screened the studies for inclusion and extracted data.
We included five studies involving 1140 women with asymptomatic bacteriuria. We did not perform meta-analysis; each trial examined different antibiotic regimens and so we were not able to pool results. In a study comparing a single dose of fosfomycin trometamol 3 g with a five-day course of cefuroxime, there was no significant difference in persistent infection (risk ratio (RR) 1.36, 95% confidence interval (CI) 0.24 to 7.75), shift to other antibiotics (RR 0.08, 95% CI 0.00 to 1.45), or in allergy or pruritus (RR 2.73, 95% CI 0.11 to 65.24). A comparison of seven-day courses of 400 mg pivmecillinam versus 500 mg ampicillin, both given four times daily, showed no significant difference in persistent infection at two weeks or recurrent infection, but there was an increase in vomiting (RR 4.57, 95% CI 1.40 to 14.90) and women were more likely to stop treatment early with pivmecillinam (RR 8.82, 95% CI 1.16 to 66.95). When cephalexin 1 g versus Miraxid(R) (pivmecillinam 200 mg and pivampicillin 250 mg) were given twice-daily for three days, there was no significant difference in persistent or recurrent infection. A one- versus seven-day course of nitrofurantoin resulted in more persistent infection with the shorter course (RR 1.76, 95% CI 1.29 to 2.40), but no significant difference in symptomatic infection at two weeks, nausea, or preterm birth. Comparing cycloserine with sulphadimidine, no significant differences in symptomatic, persistent, or recurrent infections were noted.
We cannot draw any definite conclusion on the most effective and safest antibiotic regimen for the initial treatment of asymptomatic bacteriuria in pregnancy. One study showed advantages with a longer course of nitrofurantoin, and another showed better tolerability with ampicillin compared with pivmecillinam; otherwise, there was no significant difference demonstrated between groups treated with different antibiotics. Given this lack of conclusive evidence, it may be useful for clinicians to consider factors such as cost, local availability and side effects in the selection of the best treatment option.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Preterm infants born before the 30th week of pregnancy are especially at risk of perinatal brain damage which is usually a result of cerebral ischemia or an ascending intrauterine infection. Prevention of preterm birth and early intervention given signs of imminent intrauterine infection can reduce the incidence of perinatal cerebral injury. It has been shown that administering magnesium intravenously to women at imminent risk of a preterm birth leads to a significant reduction in the likelihood of the infant developing cerebral palsy and motor skill dysfunction. It has also been demonstrated that delayed clamping of the umbilical cord after birth reduces the rate of brain hemorrhage among preterm infants by up to 50%. In addition, mesenchymal stem cells seem to have significant neuroprotective potential in animal experiments, as they increase the rate of regeneration of the damaged cerebral area. Clinical tests of these types of therapeutic intervention measures appear to be imminent. In the last trimester of pregnancy, the serum concentrations of estradiol and progesterone increase significantly. Preterm infants are removed abruptly from this estradiol and progesterone rich environment. It has been demonstrated in animal experiments that estradiol and progesterone protect the immature brain from hypoxic-ischemic lesions. However, this neuroprotective strategy has unfortunately not yet been subject to sufficient clinical investigation.
    01/2015; 2015:1-14. DOI:10.1155/2015/257139
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aufgrund hormoneller und anatomischer Veränderungen kommt es während der Schwangerschaft zu physiologischen Anpassungen des Harntraktes, besonders zu einer Erweiterung der oberen Harnwege. Die Veränderungen bedingen eine erhöhte Anfälligkeit für symptomatische Harnwegsinfekte auf dem Boden einer asymptomatischen Bakteriurie. Ein Bakteriuriescreening und eine antibiotische Behandlung bei positivem Befund werden deshalb empfohlen. Symptomatische Harnwegsinfekte werden antibiogrammgerecht therapiert; insbesondere Penicilline, Cephalosporine oder Fosfomycintrometamol kommen dabei zum Einsatz. Steine im Harntrakt werden primär spasmoanalgetisch behandelt. Bei fehlendem Steinabgang, nicht beherrschbarer Symptomatik oder persistierendem Fieber wird eine Harnleiterschiene oder eine perkutane Nephrostomie eingelegt. Funktionelle oder morphologische Veränderungen des Harntraktes können zu Problemen bei der Schwangerschaft führen. Bei Vorhandensein eines Nierentransplantates ist die Austragung einer Schwangerschaft möglich. Eine interdisziplinäre Zusammenarbeit ist in diesen Fällen unabdingbar.
    Der Gynäkologe 02/2012; 45(2). DOI:10.1007/s00129-011-2881-9
  • [Show abstract] [Hide abstract]
    ABSTRACT: Urinary tract infections are one of the most common infections in pregnant women and may produce important consequences in the mother and fetus. Prompt diagnosis and treatment are necessary to avoid those adverse events, but antibiotic drugs are not lacked of risk. Various teratogenic or toxic effects have been described with their use. Currently, there are no sufficient data to recommend a standard regimen to treat these infections. Betalactams, nitrofurantoins, or fosfomycins are appropriate regimens when based on the culture sensitivity, but the increasing problem of antibiotic resistance makes the selection more difficult.
    Current Bladder Dysfunction Reports 09/2014; 9(3). DOI:10.1007/s11884-014-0245-8

Full-text (2 Sources)

Available from
Oct 8, 2014